CAS: 1260830-14-5

Methyl 2-fluoro-3-iodobenzoate is an inhibitor of the cyclin-dependent kinase (CDK) that inhibits the activity of CDKs in vivo. The discovery and optimization of this molecule was based on a structure-based drug design approach. This compound has been shown to inhibit the activity of CDKs, which play a role in the cell cycle by phosphorylating and regulating other proteins. Methyl 2-fluoro-3-iodobenzoate is a promising candidate for anticancer treatment due to its ability to inhibit CDKs, which are associated with tumor growth.

Methyl 2-fluoro-3-iodobenzoate